(Philadelphia, PA) - The University of
Pennsylvania Center for Bioethics is pleased to announce
the establishment of the Bronstein Program on the Holocaust
and the Ethics of Human Subjects Research, supported by a multi-year
$100,000 contribution from the Sylvia and Solomon Bronstein Foundation.
"We are most thankful to the Sylvia and Solomon Bronstein
Foundation for the very generous gift -- which will permit us to
build on Penn's expertise, promote innovation, and extend the Center's
efforts in its core program area of human-subjects research, with
a focus on the Holocaust and its legacy for understanding the ethics
of clinical research," said Arthur L. Caplan, PhD,
Director of Penn's Center for Bioethics and Chair of the Department
of Medical Ethics.
The history of the holocaust provides a vast context in which to
explore, debate, and shape public policy governing the ethical conduct
and protection of human subjects. Since its inception in 1994, the
Center for Bioethics has been investigating the emerging social,
ethical and legal dimensions of human subjects research.
This significant contribution from the Sylvia and Solomon Bronstein
Foundation gives the Center the means to more effectively and synergistically
develop a common infrastructure and support base under which to
consolidate the many ongoing and potential projects in human subjects
research at Penn. It will enable the Center to leverage its own
10-year record of achievements in this area, promote innovation,
as well as attract sustained programmatic funding and faculty interest.
The principal goals of the Bronstein Program on the Holocaust and
the Ethics of Human Subjects Research will be to identify the major
ethical issues in the history of human subjects research; increase
scholarly and public knowledge about the history of the Holocaust
and its legacy on human subjects research protections; utilize history
to ground the analysis of contemporary bioethical issues; use the
history of the Holocaust to encourage debate and shape future public
responses and policies vis-à-vis human subjects research;
and foster interdisciplinary scholarly collaborations in research
As the centerpiece of the Bronstein Program, the Annual Bronstein
Lecture will bring renowned national and international scholars
to the Center speak on the subject.
Additional outcomes will include: exploration of ethical issues
in biomedical research and medicine raised by the Holocaust; policy
recommendations; major papers, book-length studies and anthologies;
publications in major scientific and popular journals; community
talks and presentations; commentary in the print and broadcast media;
subunits for high school bioethics curricula; a dedicated website;
a cadre of scholars with competency in the subject matter; and a
new generation of medical students and bioethics graduate and undergraduate
students with a sound understanding of what happened in the name
of research during the Nazi era.
The mission of the Center for Bioethics is to advance scholarly
and public understanding of the ethical, legal, social and public
policy implications of biomedical research and medicine. The Center
operates as an interdisciplinary unit of Penn’s School of
Medicine, with input from a Faculty Advisory Board of academic leaders
and an External Advisory Board of corporate and civic leaders. Its
renowned faculty-with core members based in the Department of Medical
Ethics-come from a variety of academic and clinical disciplines
including medicine, nursing, law, philosophy, psychology, sociology,
religious studies and public policy. Under the leadership of Arthur
L. Caplan, PhD, the Center has made great strides since its inception
in 1994-becoming a highly sought after resource for policy makers,
industry leaders, and the lay public wrestling with complex and
difficult bioethics issues.
The Center will mark its 10th Anniversary and celebrate its achievements
with a major public event including a symposium on the legacy of
the Terri Schiavo case on April 30 and May 1, 2006.
PENN Medicine is a $2.7 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn’s School of Medicine is ranked #2 in the nation
for receipt of NIH research funds; and ranked #4 in the nation in
U.S. News & World Report’s most recent ranking of top
research-oriented medical schools. Supporting 1,400 fulltime faculty
and 700 students, the School of Medicine is recognized worldwide
for its superior education and training of the next generation of
physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System comprises: its
flagship hospital, the Hospital of the University of Pennsylvania,
consistently rated one of the nation’s “Honor Roll”
hospitals by U.S. News & World Report; Pennsylvania Hospital,
the nation's first hospital; Penn Presbyterian Medical Center; a
faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home health care and hospice.